Seeking Alpha

Seeking Alpha Portfolio App for iPad

1,340 people get NVAX articles and Market Currents by email alert.

Get email alerts on NVAX »

NVAX

Novavax, Inc.

5/21/2013, 10:43 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 10, 5:47 PM After-hours top gainers, as of 5:30 p.m.: ENDP +3.6%. NVAX +2.8%. GRFS +2.7%. REE +2.6%. IMRS +2.4%.
AftTer-hours top losers: ET -4.0%. APTS -3.7%. SYNC -3.6%. SSRI -2.7%. VG -2.5%. Comment! [On the Move]
Tuesday, May 7, 8:05 AM Novavax (NVAX): Q1 EPS of -$0.07 misses by $0.01. Revenue of $3.8M misses by $1.74M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, May 7, 12:05 AM Notable earnings before Tuesday’s open: ACM, AFAM, AKRX, ALLT, ARCC, ARIA, BCRX, CHTR, CMLP, CNK, CQB, CRZO, CVLT, DFT, DISCA, DTV, DWRE, EMR, ENDP, FE, FOSL, HCN, HFC, HPT, HSIC, KWK, LPX, NRG, NRGY, NVAX, OAK, OMX, PQ, PRGO, RIGL, SHOO, TA, TAP, TDG, TGH, TICC, TRGT, TW, WRES, XEC 2 Comments [Earnings]
Monday, May 6, 5:30 PM Notable earnings before Tuesday's open: ACM, AFAM, AKRX, ALLT, ARCC, ARIA, BCRX, CHTR, CMLP, CNK, CQB, CRZO, CVLT, DFT, DISCA, DTV, DWRE, EMR, ENDP, FE, FOSL, HCN, HFC, HPT, HSIC, KWK, LPX, NRG, NRGY, NVAX, OAK, OMX, PQ, PRGO, RIGL, SHOO, TA, TAP, TDG, TGH, TICC, TRGT, TW, WRES, XEC Comment! [Earnings]
Monday, April 15, 9:15 AM Premarket gainers: S +16%. SVA +13%. BCRX +10%. LIFE +8%. NFP +7%. MGT +7%. TMO +6%. THRX +5%. NVAX +5%.
Losers: AAU -15%. MTL -10%. AUQ -11%. HMY -9%. NGD -8%. CEF -8%. SLW -8%. SAND -9%. KGC -7%. AUY -7%. GOLD -7%. MUX -7%. DSCO -7%. IAG -6%. SVM -6%. GG -6%. PAAS -6%. EGO -6%. AU -5%. CDE -5%. Comment! [On the Move]
Monday, April 15, 8:39 AM Biotechs rise in early trading as the death toll from the new avian flu strain jumps to 13. Sinovac (SVA) is preparing immunizations and can manufacture 30-40M doses annually, according to Bloomberg. Meanwhile, investors continue to bet BioCryst's (BCRX) peramavir could have a role to play. Premarket moves: SVA +9.6%, BCRX +7.4%, NVAX +5%. Comment! [On the Move, Healthcare]
Friday, April 5, 11:09 AM BioCryst Pharmaceuticals (BCRX +17.4%) pops on news that six deaths in China have been linked to a new strain of avian flu. BCRX is developing peramivir, which has been shown in preclinical studies to help treat highly virulent strains of influenza - including the bird flu strain known as the H5N1 virus. Other drug stocks moving higher on the news: Pure Bioscience (PURE +15.6%), Hemispherx BioPharma (HEB +13.3%), Sinovac Biotech (SVA +7.8%), and Novavax (NVAX +1.1%). Comment! [Healthcare, On the Move]
Friday, April 5, 9:10 AM Premarket gainers: XIDE +31%. NIHD +10%. NVAX +5%.
Losers: RIGL -36%. FFIV -18%. RDWR -18%. JNPR -7%. CBMX -5%. Comment! [On the Move]
Wednesday, April 3, 9:10 AM Premarket gainers: CALL +14%. CONN +10%. ZNGA +10%. ASTX +10%. UNXL +9%. AWRE +9%. OMPI +9%. NVAX +9%. ALXA +8%. MHR +7%. NFX +6%.
Losers: MSPD -19%. GPN -7%. 3 Comments [On the Move]
Tuesday, April 2, 6:08 PM Novavax (NVAX) says its respiratory syncytial virus vaccine met objectives in a Phase II clinical trial. The company says the drug was well-tolerated and there "were no clinically important differences in systemic adverse events between placebo and active vaccine recipients." Shares +7% AH. Comment! [Healthcare]
Tuesday, April 2, 5:36 PM After-hours top gainers, as of 5:15 p.m.: CALL +17%. NVAX +6%. ZOLT +6%. NFX +5%. ZNGA +5%.
After-hours top losers: KOS -10%. GPN -6%. VOD -4%. SEP -4%. OXM -3%. Comment! [On the Move]
Monday, March 18, 8:49 AM Novavax's (NVAX) vaccine for respiratory syncytial virus (RSV), which causes respiratory tract infections, produced encouraging results in preclinical studies, inducing anti-RSV antibodies in vitro and cutting infectious RSV in a cotton rat challenge model. In clinical and preclinical studies, antibodies were generated at concentrations "significantly above that found to be protective in both humans and cottons rats." The vaccine is in Phase I and Phase II trials. (PR) 1 Comment [Healthcare]
Friday, March 1, 8:03 AM Novavax (NVAX): Q4 EPS of -$0.06 misses by $0.01. Revenue of $4.56M misses by $2.48M. (PR) 1 Comment [Earnings, Breaking News, Healthcare]
Friday, March 1, 12:05 AM Notable earnings before Friday’s open: AMRC, BBY, EVEP, FWLT, HPT, MGA, NVAX, POM, XLS Comment! [Earnings]
Thursday, February 28, 5:30 PM Notable earnings before Friday’s open: AMRC, BBY, EVEP, FWLT, HPT, MGA, NVAX, POM, XLS Comment! [Earnings]
Friday, November 2, 2012, 8:05 AM Novavax (NVAX): Q3 EPS of -$0.05 in-line. Revenue of $5.8M (+16% Y/Y) misses by $2M. (PR) Comment! [Earnings, Healthcare]